ArticleJournal of translational medicine2023

The novel norcantharidin derivative DCZ5417 suppresses multiple myeloma progression by targeting the TRIP13-MAPK-YWHAE signaling pathway.

Yingcong Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.